Academic literature on the topic 'Measurement of blood cholesterol'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Measurement of blood cholesterol.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Measurement of blood cholesterol"

1

Tobert, J. A. "Blood cholesterol measurement in young adults." JAMA: The Journal of the American Medical Association 270, no. 8 (August 25, 1993): 936b—936. http://dx.doi.org/10.1001/jama.270.8.936b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lane, D. M. "Blood cholesterol measurement in young adults." JAMA: The Journal of the American Medical Association 270, no. 8 (August 25, 1993): 936c—936. http://dx.doi.org/10.1001/jama.270.8.936c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tobert, Jonathan A. "Blood Cholesterol Measurement in Young Adults." JAMA: The Journal of the American Medical Association 270, no. 8 (August 25, 1993): 936. http://dx.doi.org/10.1001/jama.1993.03510080040016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lane, Daniel M. "Blood Cholesterol Measurement in Young Adults." JAMA: The Journal of the American Medical Association 270, no. 8 (August 25, 1993): 936. http://dx.doi.org/10.1001/jama.1993.03510080040017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lewis, Carol. "Blood Cholesterol Measurement in Young Adults." JAMA: The Journal of the American Medical Association 270, no. 8 (August 25, 1993): 936. http://dx.doi.org/10.1001/jama.1993.03510080040018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Weissfeld, Joel L., and James J. Holloway. "Precision of blood cholesterol measurement and high blood cholesterol case-finding and treatment." Journal of Clinical Epidemiology 45, no. 9 (September 1992): 971–84. http://dx.doi.org/10.1016/0895-4356(92)90113-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hulley, Stephen B. "Blood Cholesterol Measurement in Young Adults-Reply." JAMA: The Journal of the American Medical Association 270, no. 8 (August 25, 1993): 937. http://dx.doi.org/10.1001/jama.1993.03510080040019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lee, Sang-Ah, Wanqing Wen, Yong-Bing Xiang, Sergio Fazio, MacRae F. Linton, Qiuyin Cai, Dake Liu, Wei Zheng, and Xiao-Ou Shu. "Stability and Reliability of Plasma Level of Lipid Biomarkers and Their Correlation with Dietary Fat Intake." Disease Markers 24, no. 2 (2008): 73–79. http://dx.doi.org/10.1155/2008/347817.

Full text
Abstract:
The reliability and stability of plasma lipid biomarkers and their association with dietary fat intake were evaluated among 48 subjects who were randomly chosen from the participants of a validation study of the population-based cohort, the Shanghai Men's Health Study (SMHS). Four spot blood samples, one taken each season, were measured for total cholesterol, triglyceride, HDL-cholesterol, and LDL-cholesterol levels. The reliability and stability of these measurements were assessed by intraclass correlation coefficients (ICC) and by the correlations between a randomly chosen measurement with the mean of measurements across seasons using a bootstrap approach. The median levels for total cholesterol, triglycerides, HDL-cholesterol, and LDL-cholesterol were 177.5, 164.5, 41.0, and 102.5 (mg/dl), respectively. The ICCs of the biomarkers ranged from 0.58 (LDL-cholesterol) to 0.83 (HDL-cholesterol). The correlation between randomly chosen spot measurements and the mean measurement were 0.91, 0.86, 0.93, and 0.83 for total cholesterol, triglycerides, HDL-cholesterol, and LDL-cholesterol, respectively. The correlations of lipid biomarkers with dietary fat intake and other lifestyle factors were comparable to other previous reports. In conclusion, this study suggests that measurements of lipid biomarkers from a single spot blood sample are a good representation of the average blood levels of these biomarkers in the study population and could be a useful tool for epidemiological studies.
APA, Harvard, Vancouver, ISO, and other styles
9

Hyman, David J., Gilles Paradis, and June A. Flora. "A Comparison of Participants and Nonparticipants in a Worksite Cholesterol Screening." American Journal of Health Promotion 7, no. 2 (November 1992): 137–41. http://dx.doi.org/10.4278/0890-1171-7.2.137.

Full text
Abstract:
Purpose. The purpose of this study is to determine if worksite cholesterol screening reaches only those who are already aware of their cholesterol and interested in lifestyle modification. Design. A voluntary worksite cholesterol screening was conducted followed by a survey of a random sample of nonparticipants. Setting. A large university worksite was the setting for this study. Subjects. Out of 9,137 university employees, 1,583 attended the voluntary screening, and a random sample of nonparticipants was obtained (n = 154), of which 87% (n = 138) responded. Measures. Subjects completed a questionnaire on health behaviors, perceived risk, self-efficacy for diet change, and attention to media messages. A capillary blood cholesterol level was also taken. Results. Nonparticipants were more likely to be male (64% versus 39%) and smokers (17% versus 9%), more likely to exercise, to have had a prior cholesterol measurement (64% versus 49%), and to “know” their cholesterol value (56% versus 26%). The two groups were otherwise similar. Over half (51%) of the participants were receiving their first cholesterol measurement. These subjects were younger, less educated, had less perceived risk, were less attentive to media messages, and more likely to be from a minority group than those individuals who had prior measurements. Discussion. These findings suggest that worksite cholesterol screening does not only reach those already aware of their cholesterols, but also can reach some persons not previously screened or concerned.
APA, Harvard, Vancouver, ISO, and other styles
10

Råstam, L., J. B. Admire, I. D. Frantz, W. Hellerstedt, D. M. Hunninghake, K. Kuba, and R. V. Luepker. "Measurement of blood cholesterol with the Reflotron analyzer evaluated." Clinical Chemistry 34, no. 2 (February 1, 1988): 426. http://dx.doi.org/10.1093/clinchem/34.2.426.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Measurement of blood cholesterol"

1

Macklin, Diana C. "A comparison of cholesterol measurements via various blood sample types." Virtual Press, 1991. http://liblink.bsu.edu/uhtbin/catkey/774768.

Full text
Abstract:
There has been inconsistencies in the performance of dry-chemistry analyzers using different blood sample types. Therefore, the purpose of this study was to determine precision and accuracy of both capillary and venous whole blood analyzed by the Reflotron (Boehringer Mannheim Diagnostics, Indianapolis, Indiana) and capillary plasma analyzed by the Ektachem DT60 (Eastman Kodak Company, Rochester, New York). Fifty subjects were recruited to provide a representative sample of cholesterol concentrations. One technician performed two fingerstick punctures and one venipuncture on each subject and analyzed the blood sample types in duplicate using each of the dry-chemistry analyzers. The methods and sample types utilized for comparison of total cholesterol are summarized below.ReflotronEktachem DT60Sigma2-Fingerstick whole2-Fingerstick plasma2-Venipuncture plasmablood2-Venipuncture whole2-Venipuncture plasmablood2-Veni uncture lasmaThe mean percent variation of the duplicate samples analyzed revealed all sample types, with the exception of fingerstick whole blood analyzed by theReflotron, met the LSP ideal goal for precision of 5 3% CV. Fingerstick wholeblood CV was 3.1%, meeting the current LSP standard of _5 5% CV for precision. The Sigma wet-chemistry assay for determination of total cholesterol was used as the reference for assessment of bias of each of the sample types. Fingerstick whole blood, via the Reflotron method, produced a positive 5.5% bias when compared to the reference, failing to meet the current LSP goal for acceptable accuracy (±5% bias). Venous whole blood analyzed using the Reflotron met this goal with a bias of +3.3%. Fingerstick plasma, via the Ektachem DT60 method, produced a bias of +2.1%, meeting the ideal LSP goal of ±3% bias. Venous plasma as measured by both the Reflotron and Ektachem DT60 also met this ideal goal (+2.0% and +1.8% bias, respectively). Overall, precision and accuracy of all sample types, with the exception of fingerstick whole blood, when analyzed by their respective dry-chemistry analyzer was acceptable.
School of Physical Education
APA, Harvard, Vancouver, ISO, and other styles
2

Govender, Gwensweri, University of Western Sydney, and College of Science Technology and Environment. "Fabrication and characterisation of eletrochemical biosensors for the determination of cholesterol." THESIS_CSTE_XXX_Govender_G.xml, 2001. http://handle.uws.edu.au:8081/1959.7/461.

Full text
Abstract:
During the course of this study, an extensive investigation was conducted into the measurement of free and total cholesterol by fabrication of cholesterol biosensors. Specific areas investigated in-depth included the immobilisation of enzymes into conducting polypyrrole (PPy) film, bovine serum albumin-glutaraldehyde (BSA-GLA) gel and a hybrid bi-layer of PPy and BSA-GLA. Key parameters for the reliable measurement of cholesterol were optimised. The optimum parameters
Doctor of Philosophy (PhD)
APA, Harvard, Vancouver, ISO, and other styles
3

Govender, Gwensweri. "Fabrication and characterisation of eletrochemical biosensors for the determination of cholesterol." Thesis, View thesis, 2001. http://handle.uws.edu.au:8081/1959.7/461.

Full text
Abstract:
During the course of this study, an extensive investigation was conducted into the measurement of free and total cholesterol by fabrication of cholesterol biosensors. Specific areas investigated in-depth included the immobilisation of enzymes into conducting polypyrrole (PPy) film, bovine serum albumin-glutaraldehyde (BSA-GLA) gel and a hybrid bi-layer of PPy and BSA-GLA. Key parameters for the reliable measurement of cholesterol were optimised. The optimum parameters
APA, Harvard, Vancouver, ISO, and other styles
4

Aristovich, E. "Non-invasive measurement of cholesterol in human blood by impedance technique : an investigation by finite element field modelling." Thesis, City University London, 2014. http://openaccess.city.ac.uk/8343/.

Full text
Abstract:
The main topic of this work is detection of solid particles suspended in conductive medium and development of methodologies for determining cholesterol levels in human blood non-invasively by electrical impedance technique. The main part of this research is focused on the development of methodologies for numerical finite element (FE) modelling of simplified blood-cholesterol system, representing a real measurement system. This has been done first in 2D, to prove the concept and then in 3D, to take into account all of the effects that would only be present in 3D system as well as taking into account that there is a fully 3D problem in the heart of presented research. The proposed model has been tested in various extreme cases and theoretical and some experimental validations have been carried out to establish a degree of confidence in the modelling methodologies developed. This included novel way of model simplification by introduction of particle coagulation. This method has been proven to be successful replacement of effective conductivity method, used in the past. It has been tested against variation in physiological parameters, such as particle concentration and distribution, and material properties, such as particle ,conductivities. In 3D modelling cases the red blood cells (RBC) have been added to further increase the complexity of the system. Several case studies were used to help analyse which physical parameters of RBC would have the biggest impact on system’s impedance. Results were validated against experimental data where possible. This allowed extension of proposed methodology to non-spherical particles modelling. The other methodology adopted in this work applies to the electrode modelling. All electrodes are modelled as hollows. This tactic has been proven to work. It was validated both theoretically and by comparing computational model results with experiment results (BERG, City University London). In Conclusions, it is discussed that both methodologies can be used outside of current research in electromagnetic simulations of less conductive particles in conductive solvent and in cases where electrode material is not known. Modelling investigations of the simplified blood-cholesterol systems using the 2D and 3D FE modelling methodologies developed in this work have shown that it should be possible to measure cholesterol levels in human blood by impedance technique. Opinion sought from clinical staff highlight that this can potentially improve patient care by minimizing time needed for tests and human error (by shortening the number of people involved in testing). The work also establishes and discusses the need for further work, both theoretical and experimental for development of a measuring device for non-invasive measurement of cholesterol in human blood by impedance technique.
APA, Harvard, Vancouver, ISO, and other styles
5

Vela-Melton, Dorothy Louise. "Self-esteem and blood pressure, cholesterol, thyroxine and leukocytes." CSUSB ScholarWorks, 1991. https://scholarworks.lib.csusb.edu/etd-project/460.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lewington, Sarah. "Blood pressure, cholesterol and premature death : towards the real relationships." Thesis, University of Oxford, 1999. http://ora.ox.ac.uk/objects/uuid:517a1b6c-4752-46e7-868b-48a4ea078e69.

Full text
Abstract:
This thesis is based on a worldwide overview (meta-analysis) of prospective observational studies of blood pressure and cholesterol, involving a centralised collection of data on over one million individuals from 59 studies, which I have co- ordinated since its inception. Analytically, the aim has been to develop and to use appropriate statistical techniques to assess the age- and sex-specific associations of usual blood pressure and of usual cholesterol with cause-specific mortality. Since the data set is uniquely large, and because appropriate methods of analysis (with full account taken of the time-dependent nature of the regression dilution bias) have been developed and used, these associations have been established more reliably. An integral part of the methodological element of the thesis has been to investigate the systematic underestimation of associations between risk factor and disease that are obtained when only a single baseline measurement is used to assess levels of such risk factors (the regression dilution bias). The extent of this bias has been investigated in each study that had repeat measurements of risk factors during follow-up. One particularly novel aspect has been the emphasis on, and methods developed to account for, the regression dilution bias in several studies simultaneously and in an appropriately time-dependent way. This thesis illustrates the extent to which random error and inappropriate statistical analysis lead to misleading conclusions concerning the importance of blood pressure and blood cholesterol, particularly in premature death. Only by studying adequate numbers of deaths (136,000 deaths among 1 million adults during 13 million person- years of follow-up) and by using appropriate statistical techniques - taking proper account of (a) the regression dilution bias; (b) the full range of blood pressure and cholesterol; (c) the opposing effects of HDL.and the remaining non-HDL cholesterol; and (d) age at death - did it become possible to provide reliable results on the true relationships between blood pressure, cholesterol fractions and vascular and other causes of death. These analyses have demonstrated reliably that, as causes of IHD death in early middle age, blood pressure and blood lipids are three to five times more important than suggested by inappropriate analyses, with no clinically relevant inverse associations with cancer or other non-vascular mortality (except, surprisingly, COPD).
APA, Harvard, Vancouver, ISO, and other styles
7

Huang, Tingyu Tina, and 黄亭语. "Systematic review: effect of tartary buckwheat in controlling blood cholesterol." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46937298.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wilson, Stephanie Helen. "Pathogenesis and treatment of cholesterol-related early vascular injury." Thesis, The University of Sydney, 2000. https://hdl.handle.net/2123/28453.

Full text
Abstract:
This thesis describes studies into the pathogenesis of Cholesterol—related early vascular injury. In addition, this thesis examines the potential reversibility of this injury with 2 agents: a) simvastatin, an HMGCoA reductase inhibitor, in a model independent of any reduction in lipids and 2) high dose aspirin. Hypercholesterolaemia led to a decrease in NO bioavailability, in association with a decrease in the enzyme, endothelial nitric oxide synthase and increased oxidative stress. In addition, there was an increase in the pro—inflammatory transcription factor, NF—KB, in the intima of the epicardial coronary arteries. Moreover, activated NF—KB was present in macrophages, foam cells and vascular smooth muscle cells in coronary atheromatous plaque and its expression increased in unstable coronary syndromes. These data support a role for NF—KB in the pathogenesis of early atherosclerosis and the development of unstable coronary syndromes. In addition, this thesis demonstrated for the first time that simvastatin, an HMGCoA reductase inhibitor, preserves endothelium—dependent vasorelaxation in both large and small coronary vessels in porcine experimental HC, despite no reduction in plasma lipids. This effect was associated with normalisation of eNOS protein levels. Furthermore, in vivo plasma markers of oxidative stress were attenuated by treatment with simvastatin. However, there was no attenuation in the activation of the proinflammatory transcription factor, NF—KB. These studies suggest a role for the HMGCoA reductase inhibitors in reducing cardiac morbidity and mortality, beyond their effect on cholesterol levels. The current studies also demonstrated that high dose aspirin therapy preserved endothelial function in large coronary vessels. This alteration in the generation of prostanoids in favour of vasodilatation may be an important component of the therapeutic benefit of aspirin in HC-induced atherosclerosis. In summary, results of studies described in this thesis provide insights into the molecular mechanisms that may be responsible for early vascular injury in hypercholesterolaemia and its reversibility with the therapeutic agents, simvastatin and high dose aspirin.
APA, Harvard, Vancouver, ISO, and other styles
9

Neubauer, Tamara E. "Cholesterol reduction in men : an experimental investigation of intensive treatment with frequent feedback versus a simple educational treatment /." Thesis, This resource online, 1990. http://scholar.lib.vt.edu/theses/available/etd-03122009-040807/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lee, Sun Min. "Studies of the Mechanism of Plasma Cholesterol Esterification in Aged Rats." Thesis, University of North Texas, 1989. https://digital.library.unt.edu/ark:/67531/metadc331051/.

Full text
Abstract:
The study was performed to determine factors influencing the esteriflcation of plasma cholesterol in young and aged rats. The distribution of LCAT activity was determined following gel nitration chromatography and ultracentrifugation of whole plasma respectively. When rat plasma was fractionated on a Bio-Gel A-5 Mcolumn, LCAT activity was found to be associated with the HDL fraction. A similar result was observed upon 24 hr density gradient ultracentrifugation of the plasma. However, following prolonged 40 hr preparative ultracentrifugation, the majority of the LCAT activity was displaced into the lipoprotein-free infranatant fraction (d> 1.225 g/ml). The dissociation of LCAT from the HDL fraction occured to a smaller extent in aged rat plasma than in young rat plasma. Plasma incubation (37°C) experiments followed by the isolation of lipoproteins and the subsequent analysis of their cholesterol content revealed that in vitro net esteriflcation of free cholesterol (FC) by LCAT as well as the fractional ufilization of HDL-FC as substrate were lower in the plasma of the aged animal as compared to that of the young animal despite the fact that the total pool of FC was higher in the former. The net transfer of FC from lower density lipoproteins (d<1.07 g/ml) to HDL provided the FC (in addition to HDL-FC) for esteriflcation in the plasma of both young and aged rats, and this process was not substantially affected by aging. Substrate specificity studies indicated that HDL from young rats was a better substrate for LCAT than the HDL from aged rats. The HDL isolated from the plasma of aged rats was enriched with apo E and had a considerably higher molecular weight than the HDL from young rat plasma. The ratio of phosphatidyl choline/sphingomyelin was lower in the HDL of aged rats. These data suggest that the decreased plasma cholesterol esteriflcation in aged rats is due to changes in the composition and size of the lipoprotein substrate (HDL).
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Measurement of blood cholesterol"

1

Program, National Cholesterol Education Program (U S. ). Laboratory Standardization Panel of the National Cholesterol Education. Recommendations for improving cholesterol measurement: A report. Bethesda, Md: U.S. Dept. of Health and Human Services, Public Health Service, National Institute of Health, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

National Heart, Lung, and Blood Institute. and National Institutes of Health (U.S.), eds. Recommendations for improving cholesterol measurement: Executive summary. Bethesda, Md: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

National Cholesterol Education Program (U.S.). Laboratory Standardization Panel. Executive summary: Current status of blood cholesterol measurement in clinical laboratories in the United States : a report from the Laboratory Standardization Panel of the National Cholesterol Education Program. [Bethesda, Md.?]: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

National Health and Medical Research Council (Australia). Working Party on Cholesterol Screening. Guidelines for blood cholesterol measurement in the community: Report of. Canberra: Australian Government Publishing Service, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chan, Kwai-Cheung. Cholesterol measurement: Variability in methods and test results : statement of Kwai-Cheung Chan, Director of Program Evaluation in Physical Systems Areas, Program Evaluation and Methodology Division, before the Subcommittee on Technology, Committee on Science, House of Representatives. Washington, D.C: The Office, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

National Committee for Clinical Laboratory Standards. Preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurement procedures: Approved guideline. Wayne, Pa: National Committee for Clinical Laboratory Standards, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Savoie, I. Supporting clinical practice guidelines development: An appraisal of existing cholesterol testing guidelines. Vancouver: B.C. Office of Health Technology Assessment, Centre for Health Services & Policy Research, University of British Columbia, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Technology, United States Congress House Committee on Science Subcommittee on. Cholesterol measurement: Error and variability : hearing before the Subcommittee on Technology of the Committee on Science, U.S. House of Representatives, One Hundred Fourth Congress, first session, February 14, 1995. Washington: U.S. G.P.O., 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

United States. Congress. House. Committee on Science. Subcommittee on Technology. Cholesterol measurement: Error and variability : hearing before the Subcommittee on Technology of the Committee on Science, U.S. House of Representatives, One Hundred Fourth Congress, first session, February 14, 1995. Washington: U.S. G.P.O., 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Office, General Accounting. Cholesterol measurement: Test accuracy and factors that influence cholesterol levels : report to the Chairman, Subcommittee on Investigations and Oversight, Committee on Science, Space, and Technology, House of Representatives. Washington, D.C: The Office, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Measurement of blood cholesterol"

1

Hernandez-Zacarias, B., A. W. Muñoz-Arpaiz, G. Romo-Cardenas, A. Guillen-Peralta, J. Alvarez-Arana, and I. Chable-Hernández. "Study of the Sensitivity on the Measurement of the Prevalence of Total Cholesterol in Blood Serum by Interferometric Techniques." In IFMBE Proceedings, 1591–94. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-19387-8_387.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jaranilla, Jawali, and Thomas E. Kottke. "Blood Cholesterol." In Encyclopedia of Immigrant Health, 284–88. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-5659-0_84.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cohen Tervaert, Jan Willem. "Cholesterol and Modifications of Cholesterol in Rheumatic Disorders." In Inflammatory Diseases of Blood Vessels, 473–83. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118355244.ch43.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Heller, Lois Jane, Celette Sugg Skinner, A. Janet Tomiyama, Elissa S. Epel, Peter A. Hall, Julia Allan, Lara LaCaille, et al. "Total Cholesterol in the Blood." In Encyclopedia of Behavioral Medicine, 1985. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_101802.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Metoki, Hirohito. "Ambulatory Blood Pressure Measurement and Home Blood Pressure Measurement." In Preeclampsia, 199–208. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-5891-2_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Aviram, Michael. "Effect of Lipoproteins and Platelets on Macrophage Cholesterol Metabolism." In Blood Cell Biochemistry, 179–208. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4757-9531-8_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ginty, Annie T. "Blood Pressure, Measurement of." In Encyclopedia of Behavioral Medicine, 276. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_444.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wideman, Timothy H., Michael J. L. Sullivan, Shuji Inada, David McIntyre, Masayoshi Kumagai, Naoya Yahagi, J. Rick Turner, et al. "Blood Pressure, Measurement of." In Encyclopedia of Behavioral Medicine, 240–41. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_444.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wagner, Stefan. "Blood Pressure Self-Measurement." In Advances in Experimental Medicine and Biology, 97–107. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/5584_2016_151.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

O’brien, Eoin. "Conventional blood pressure measurement." In Developments in Cardiovascular Medicine, 13–22. Dordrecht: Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-009-1647-0_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Measurement of blood cholesterol"

1

Khan, Ayesha, and Shruti Dorai. "159 Improving baseline measurement of blood glucose and cholesterol levels in acute stroke patients: a quality improvement project." In Leaders in Healthcare Conference, 17–20 November 2020. BMJ Publishing Group Ltd, 2020. http://dx.doi.org/10.1136/leader-2020-fmlm.159.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ley, Obdulia, and Taehong Kim. "Numerical Prediction of Atherosclerotic Plaque Temperature as a Function of Plaque Size and Composition." In ASME 2005 International Mechanical Engineering Congress and Exposition. ASMEDC, 2005. http://dx.doi.org/10.1115/imece2005-80853.

Full text
Abstract:
Atherosclerotic plaque or cholesterol deposits in arteries with high likelihood of rupture experience an inflammatory cascade that produces a temperature inhomogeneity within the affected artery. As a result, a new and promising method to detect plaque vulnerability is based on the measurement of the arterial wall temperature (AWT). In this paper, the energy equation is solved to determine the plaque temperature distribution on the vessel wall considering blood flow, inflammatory cell density, and plaque size. Two different blood vessel shapes are considered: a stenotic straight artery, and an arterial bend, both with geometry and dimensions that correspond to the human aorta and a human coronary artery, respectively. These vessels were selected because atherosclerotic plaques are commonly encountered in such arteries. The plaque is located in the sites of low shear stress and variations in its volume and cell density are considered. The heat generation in the vulnerable plaque due to macrophage activation in inflammatory processes is taken from the literature. This paper presents steady state calculations. Reynolds numbers of 300 and 500 are used to represent maximum and minimum velocities during the cardiac cycle. Plots of plaque and arterial wall temperature as a function of macrophage concentration, and activation stage are presented; and the maximum plaque temperature is compared with arterial wall temperature values found in the literature.
APA, Harvard, Vancouver, ISO, and other styles
3

Prasad, D. N., Sumaya Al-Maadeed, Asan Abdul Muthalif, and Kishor Kumar Sadasivuni. "Optical Non-invasive Technique for Cholesterol Detection in Blood." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0076.

Full text
Abstract:
The aim of this research is to design and develop a non-invasive cholesterol sensor based on the principle of light absorption. The current existing invasive methods can be replaced with non-invasive techniques. The interaction of light with matter has been utilized to design a smart device that measures blood cholesterol without collecting blood samples. It requires developing an optical sensor that focuses on the use of near infrared (NIR)-LED.
APA, Harvard, Vancouver, ISO, and other styles
4

"The effect of cholesterol lowering drugs on vitamin D in people with family high blood cholesterol." In International Conference on Medicine, Public Health and Biological Sciences. CASRP Publishing Company, Ltd. Uk, 2016. http://dx.doi.org/10.18869/mphbs.2016.83.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gul, Burak Kursat, and Cetin Kurnaz. "Detection of high level cholesterol in blood with iris analysis." In 2016 20th National Biomedical Engineering Meeting (BIYOMUT). IEEE, 2016. http://dx.doi.org/10.1109/biyomut.2016.7849389.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shen, Jiatong. "Research on the Correlation between Cholesterol Level, Diet, and Blood Pressure." In International Conference on Health Big Data and Intelligent Healthcare. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011373400003438.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Martinakova, Z., J. Horilova, I. Lajdova, and A. Marcek Chorvatova. "Time-resolved fluorescence monitoring of cholesterol in peripheral blood mononuclear cells." In XIX Polish-Slovak-Czech Optical Conference on Wave and Quantum Aspects of Contemporary Optics, edited by Agnieszka Popiolek-Masajada and Waclaw Urbanczyk. SPIE, 2014. http://dx.doi.org/10.1117/12.2074288.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Badran, Daniel, Paulo Abreu, and Maria Teresa Restivo. "Blood Pressure Measurement." In 2019 5th Experiment Conference (exp.at'19). IEEE, 2019. http://dx.doi.org/10.1109/expat.2019.8876538.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chang, Hsueh-Chia. "Micro-Fluidic Technologies for Blood Diagnostics." In ASME 2004 2nd International Conference on Microchannels and Minichannels. ASMEDC, 2004. http://dx.doi.org/10.1115/icmm2004-2315.

Full text
Abstract:
There is considerable market interest for miniature blood diagnostic kits for cholesterol, ovulation, glucose, bacteria, leukemia cells, coagulation tests, drugs etc. However, the presence of blood cells in the blood samples introduces an array of micro-fluidic issues that have become main obstacles to commercialization of these products. We discuss some of these anomalous micro-fluidic features of blood here. Some devices and designs developed at the Notre Dame Center for Micro-fluidics and Medical Diagnostics will be presented as solutions to these micro-fluidic challenges.
APA, Harvard, Vancouver, ISO, and other styles
10

Jiang, Jingying, Lingling Zhang, Qiliang Gong, and Kexin Xu. "Influence of cholesterol on non-invasive blood glucose sensing studied with NIR spectroscopy." In SPIE BiOS. SPIE, 2011. http://dx.doi.org/10.1117/12.876191.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Measurement of blood cholesterol"

1

Bhattarai, Kusha. Investigation of blood pressure measurement using a hydraulic occlusive cuff. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.3131.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gao, Hui, Chen Gong, Shi-chun Shen, Jia-ying Zhao, Dou-dou Xu, Fang-biao Tao, Yang Wang, and Xiao-chen Fan. A systematic review on the associations between prenatal phthalate exposure and childhood glycolipid metabolism and blood pressure: evidence from epidemiological studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2022. http://dx.doi.org/10.37766/inplasy2022.6.0111.

Full text
Abstract:
Review question / Objective: The present systematic review was performed to obtain a summary of epidemiological evidence on the relationships of in utero exposure to phthalates with childhood glycolipid metabolism and blood pressure. Condition being studied: Childhood cardiovascular risk factors including blood pressure, lipid profile (e.g., triglycerides, total cholesterol, HDL−C, LDL−C) and glucose metabolism (e.g., insulin, insulin resistance, insulin sensitivity, glucose) were the interested outcomes. Eligibility criteria: In brief, epidemiological studies including cohort study, case-control study and cross-sectional survey were screened. Studies regarding relationships between human exposure to organophosphate esters and neurotoxicity were possible eligible for the present systematic review. The adverse neurodevelopmental outcomes included development of cognition, behavior, motor, brain change, emotion, etc. Studies that did not meet the above criteria were not included in this systematic review.
APA, Harvard, Vancouver, ISO, and other styles
3

Chen, Jiankun, Yingming Gu, Lihong Yin, Minyi He, Na Liu, Yue Lu, Changcai Xie, Jiqiang Li, and Yu Chen. Network meta-analysis of curative efficacy of different acupuncture methods on obesity combined with insulin resistance. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2022. http://dx.doi.org/10.37766/inplasy2022.8.0075.

Full text
Abstract:
Review question / Objective: Population:Patients diagnosed as obesity with insulin resistance. Obesity reference: Consensus of experts on the Prevention and treatment of adult obesity in China in 2011 and Consensus of Chinese experts on medical nutrition therapy for overweight/obesity in 2016 were developed by the Obesity Group of Chinese Society of Endocrinology(CSE); BMI≥28. IR reference: According to the Expert opinions on insulin resistance evaluation published by Chinese Diabetes Society, HOMA-IR≥2.68 is regarded as the standard for the diagnosis of IR. Regardless of age, gender and course of disease. Patients diagnosed as obesity with insulin resistance. Intervention:Any kind of acupuncture, moxibustion, acupuncture+moxibustion, warm acupuncture, electropuncture, auricular point, acupoint application and acupoint catgut embedding. Comparison:Other acupuncture treatments, Drug therapy or blank control. Outcome:Primary outcomes: ①Fasting blood-glucose (FBG); ②Fasting serum insulin (FINS); ③Homeostasis model assessment-IR (HOMA-IR); ④Body Mass Index (BMI). Secondary outcomes: ①Waistline; ②Waist-hip ratio;③Triglyceride (TG); ④Total cholesterol (TC); ⑤High-density lipoprotein (HDL); ⑥Low-density lipoprotein (LDL). Study: Randomized controlled trials (RCTs) of different acupuncture methods in the treatment on obesity with insulin resistance, blind method and language are not limited. Randomized controlled trials (RCTs).
APA, Harvard, Vancouver, ISO, and other styles
4

echiam, Ostchega, Tatiana Nwankwo, Michele Chiappa, Jessica Graber, and Nguyen Duong T. Series 2–187: Comparing Blood Pressure Values Obtained by Two Different Protocols: National Health and Nutrition Examination Survey, 2017–2018. National Center for Health Statistics, April 2021. http://dx.doi.org/10.15620/cdc:104185.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Brosh, Arieh, David Robertshaw, Yoav Aharoni, Zvi Holzer, Mario Gutman, and Amichai Arieli. Estimation of Energy Expenditure of Free Living and Growing Domesticated Ruminants by Heart Rate Measurement. United States Department of Agriculture, April 2002. http://dx.doi.org/10.32747/2002.7580685.bard.

Full text
Abstract:
Research objectives were: 1) To study the effect of diet energy density, level of exercise, thermal conditions and reproductive state on cardiovascular function as it relates to oxygen (O2) mobilization. 2) To validate the use of heart rate (HR) to predict energy expenditure (EE) of ruminants, by measuring and calculating the energy balance components at different productive and reproductive states. 3) To validate the use of HR to identify changes in the metabolizable energy (ME) and ME intake (MEI) of grazing ruminants. Background: The development of an effective method for the measurement of EE is essential for understanding the management of both grazing and confined feedlot animals. The use of HR as a method of estimating EE in free-ranging large ruminants has been limited by the availability of suitable field monitoring equipment and by the absence of empirical understanding of the relationship between cardiac function and metabolic rate. Recent developments in microelectronics provide a good opportunity to use small HR devices to monitor free-range animals. The estimation of O2 uptake (VO2) of animals from their HR has to be based upon a consistent relationship between HR and VO2. The question as to whether, or to what extent, feeding level, environmental conditions and reproductive state affect such a relationship is still unanswered. Studies on the basic physiology of O2 mobilization (in USA) and field and feedlot-based investigations (in Israel) covered a , variety of conditions in order to investigate the possibilities of using HR to estimate EE. In USA the physiological studies conducted using animals with implanted flow probes, show that: I) although stroke volume decreases during intense exercise, VO2 per one heart beat per kgBW0.75 (O2 Pulse, O2P) actually increases and measurement of EE by HR and constant O2P may underestimate VO2unless the slope of the regression relating to heart rate and VO2 is also determined, 2) alterations in VO2 associated with the level of feeding and the effects of feeding itself have no effect on O2P, 3) both pregnancy and lactation may increase blood volume, especially lactation; but they have no effect on O2P, 4) ambient temperature in the range of 15 to 25°C in the resting animal has no effect on O2P, and 5) severe heat stress, induced by exercise, elevates body temperature to a sufficient extent that 14% of cardiac output may be required to dissipate the heat generated by exercise rather than for O2 transport. However, this is an unusual situation and its affect on EE estimation in a freely grazing animal, especially when heart rate is monitored over several days, is minor. In Israel three experiments were carried out in the hot summer to define changes in O2P attributable to changes in the time of day or In the heat load. The animals used were lambs and young calves in the growing phase and highly yielding dairy cows. In the growing animals the time of day, or the heat load, affected HR and VO2, but had no effect on O2P. On the other hand, the O2P measured in lactating cows was affected by the heat load; this is similar to the finding in the USA study of sheep. Energy balance trials were conducted to compare MEI recovery by the retained energy (RE) and by EE as measured by HR and O2P. The trial hypothesis was that if HR reliably estimated EE, the MEI proportion to (EE+RE) would not be significantly different from 1.0. Beef cows along a year of their reproductive cycle and growing lambs were used. The MEI recoveries of both trials were not significantly different from 1.0, 1.062+0.026 and 0.957+0.024 respectively. The cows' reproductive state did not affect the O2P, which is similar to the finding in the USA study. Pasture ME content and animal variables such as HR, VO2, O2P and EE of cows on grazing and in confinement were measured throughout three years under twenty-nine combinations of herbage quality and cows' reproductive state. In twelve grazing states, individual faecal output (FO) was measured and MEI was calculated. Regression analyses of the EE and RE dependent on MEI were highly significant (P<0.001). The predicted values of EE at zero intake (78 kcal/kgBW0.75), were similar to those estimated by NRC (1984). The EE at maintenance condition of the grazing cows (EE=MEI, 125 kcal/kgBW0.75) which are in the range of 96.1 to 125.5 as presented by NRC (1996 pp 6-7) for beef cows. Average daily HR and EE were significantly increased by lactation, P<0.001 and P<0.02 respectively. Grazing ME significantly increased HR and EE, P<0.001 and P<0.00l respectively. In contradiction to the finding in confined ewes and cows, the O2P of the grazing cows was significantly affected by the combined treatments (P<0.00l ); this effect was significantly related to the diet ME (P<0.00l ) and consequently to the MEI (P<0.03). Grazing significantly increased O2P compared to confinement. So, when EE of grazing animals during a certain season of the year is estimated using the HR method, the O2P must be re measured whenever grazing ME changes. A high correlation (R2>0.96) of group average EE and of HR dependency on MEI was also found in confined cows, which were fed six different diets and in growing lambs on three diets. In conclusion, the studies conducted in USA and in Israel investigated in depth the physiological mechanisms of cardiovascular and O2 mobilization, and went on to investigate a wide variety of ruminant species, ages, reproductive states, diets ME, time of intake and time of day, and compared these variables under grazing and confinement conditions. From these combined studies we can conclude that EE can be determined from HR measurements during several days, multiplied by O2P measured over a short period of time (10-15 min). The study showed that RE could be determined during the growing phase without slaughtering. In the near future the development microelectronic devices will enable wide use of the HR method to determine EE and energy balance. It will open new scopes of physiological and agricultural research with minimizes strain on animals. The method also has a high potential as a tool for herd management.
APA, Harvard, Vancouver, ISO, and other styles
6

Luo, Pan, Fuqiang Gao, Nianfei Zhang, Hongwei Yu, Ke Xu, and Peng Xu. Evaluation of tranexamic acid after total hip arthroplasty over 60 years old in China: a Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2022. http://dx.doi.org/10.37766/inplasy2022.1.0048.

Full text
Abstract:
Review question / Objective: The purpose of this meta-analysis was to evaluate the efficacy of tranexamic acid after total hip arthroplasty in patients older than 60 years old in China by meta-analysis. Participant or population: All trials included in our study meet the following criteria: (1) All studies were original RCTs; (2) The mean age of patients for each study was ≥ 60 years old; (3) Patients were received total hip arthroplasty in all studies; (4) All studies included oral and iv or topical groups, with a comparison of outcomes between the two groups; (5) The full text of the included literature can be obtained, and the measurement data of hemoglobin drop, total blood loss, transfusion rate, complication, length of stay can be extracted. The following studies were excluded from the meta-analysis: nonrandomized studies; the patients with age<60; studies not suitable with the inclusive criteria; and articles for which we were unable to obtain the full text and relevant data for pooled analysis.
APA, Harvard, Vancouver, ISO, and other styles
7

Noga, Edward J., Ramy R. Avtalion, and Michael Levy. Comparison of the Immune Response of Striped Bass and Hybrid Bass. United States Department of Agriculture, August 1993. http://dx.doi.org/10.32747/1993.7568749.bard.

Full text
Abstract:
We developed methods for examining the pathophysical response of striped bass and hybrid bass to various forms of stress. This involved development of techniques for the measurement of lysozyme, mitogen blastogenesis, mixed lymphocyte reaction, and oxidative burst, which are important general indicators of systemic immune function. We also examined local immune defenses (epithelial integrity), as well as homeostatic indicators in blood, including osmotic balance and glucose. Acute stress resulted in significant perturbations in a number of parameters, including glucose, electrolytes, osmolarity, lysozyme, and mixed lymphocyte reaction. Most significantly, acute confinement stress resulted in severe damage to the epidermal epithelium, as indicated by the rapid (within 2 hr) development of erosions and ulcerations on various fins. There were significant differences in the resting levels of some immune functions between striped bass and hybrid bass, including response to mitogens in the leukocyte blastogenesis test. Our studies also revealed that there were significant differences in how striped bass and hybrid bass respond to stress, with striped bass being much more severely affected by stress than the hybrid. This was reflected in more severe changes in glucose, cortisol dynamics, and plasma lysozyme. Most significantly, striped bass developed more severe idiopathic skin ulceration after stress, which may be a major reason why this fish is so prone to develop opportunistic bacterial and fungal infections after stress. Hybrid bass injected with equine serum albumin developed a typical humoral immune response, with peak antibody production 28 days after primary immunization. Fish that were exposed to a chronic stress after a primary immunization showed almost complete inhibition of antibody production.
APA, Harvard, Vancouver, ISO, and other styles
8

Treadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel, and Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), March 2021. http://dx.doi.org/10.23970/ahrqepctb38.

Full text
Abstract:
Background. Automated-entry consumer devices that collect and transmit patient-generated health data (PGHD) are being evaluated as potential tools to aid in the management of chronic diseases. The need exists to evaluate the evidence regarding consumer PGHD technologies, particularly for devices that have not gone through Food and Drug Administration evaluation. Purpose. To summarize the research related to automated-entry consumer health technologies that provide PGHD for the prevention or management of 11 chronic diseases. Methods. The project scope was determined through discussions with Key Informants. We searched MEDLINE and EMBASE (via EMBASE.com), In-Process MEDLINE and PubMed unique content (via PubMed.gov), and the Cochrane Database of Systematic Reviews for systematic reviews or controlled trials. We also searched ClinicalTrials.gov for ongoing studies. We assessed risk of bias and extracted data on health outcomes, surrogate outcomes, usability, sustainability, cost-effectiveness outcomes (quantifying the tradeoffs between health effects and cost), process outcomes, and other characteristics related to PGHD technologies. For isolated effects on health outcomes, we classified the results in one of four categories: (1) likely no effect, (2) unclear, (3) possible positive effect, or (4) likely positive effect. When we categorized the data as “unclear” based solely on health outcomes, we then examined and classified surrogate outcomes for that particular clinical condition. Findings. We identified 114 unique studies that met inclusion criteria. The largest number of studies addressed patients with hypertension (51 studies) and obesity (43 studies). Eighty-four trials used a single PGHD device, 23 used 2 PGHD devices, and the other 7 used 3 or more PGHD devices. Pedometers, blood pressure (BP) monitors, and scales were commonly used in the same studies. Overall, we found a “possible positive effect” of PGHD interventions on health outcomes for coronary artery disease, heart failure, and asthma. For obesity, we rated the health outcomes as unclear, and the surrogate outcomes (body mass index/weight) as likely no effect. For hypertension, we rated the health outcomes as unclear, and the surrogate outcomes (systolic BP/diastolic BP) as possible positive effect. For cardiac arrhythmias or conduction abnormalities we rated the health outcomes as unclear and the surrogate outcome (time to arrhythmia detection) as likely positive effect. The findings were “unclear” regarding PGHD interventions for diabetes prevention, sleep apnea, stroke, Parkinson’s disease, and chronic obstructive pulmonary disease. Most studies did not report harms related to PGHD interventions; the relatively few harms reported were minor and transient, with event rates usually comparable to harms in the control groups. Few studies reported cost-effectiveness analyses, and only for PGHD interventions for hypertension, coronary artery disease, and chronic obstructive pulmonary disease; the findings were variable across different chronic conditions and devices. Patient adherence to PGHD interventions was highly variable across studies, but patient acceptance/satisfaction and usability was generally fair to good. However, device engineers independently evaluated consumer wearable and handheld BP monitors and considered the user experience to be poor, while their assessment of smartphone-based electrocardiogram monitors found the user experience to be good. Student volunteers involved in device usability testing of the Weight Watchers Online app found it well-designed and relatively easy to use. Implications. Multiple randomized controlled trials (RCTs) have evaluated some PGHD technologies (e.g., pedometers, scales, BP monitors), particularly for obesity and hypertension, but health outcomes were generally underreported. We found evidence suggesting a possible positive effect of PGHD interventions on health outcomes for four chronic conditions. Lack of reporting of health outcomes and insufficient statistical power to assess these outcomes were the main reasons for “unclear” ratings. The majority of studies on PGHD technologies still focus on non-health-related outcomes. Future RCTs should focus on measurement of health outcomes. Furthermore, future RCTs should be designed to isolate the effect of the PGHD intervention from other components in a multicomponent intervention.
APA, Harvard, Vancouver, ISO, and other styles
9

The benefits of commonly used blood pressure and cholesterol lowering treatment can last 16 years. National Institute for Health Research, January 2019. http://dx.doi.org/10.3310/signal-000710.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Best Practices for Cardiovascular Disease Prevention Programs. National Center for Chronic Disease Prevention and Health Promotion, November 2022. http://dx.doi.org/10.15620/cdc:122281.

Full text
Abstract:
The Best Practices Guide for CVD Prevention describes and summarizes scientific evidence behind 8 effective strategies for lowering high blood pressure and cholesterol levels that can be implemented in health care systems and that involve community-clinical links. The guide is a resource for state and local health departments, decision makers, public health professionals, and other stakeholders interested in using proven strategies to improve cardiovascular health.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography